Avidity Biosciences Analyst Ratings
4 Analysts Assess Arcellx: What You Need To Know
Teva Settles Patent Litigation With Amicus
B of A Securities Maintains Buy on Amicus Therapeutics, Raises Price Target to $15
Expert Outlook: Amicus Therapeutics Through The Eyes Of 4 Analysts
Capricor Reports Positive Long-term Data for DMD Drug Deramiocel
Amicus Therapeutics Analyst Ratings
Capitulation in Biotech Is Near, as Well as a Rally – Piper Sandler
Sanofi, Denali Face Another Mid-stage Setback for Neurology Therapy
JP Morgan Maintains Overweight on Denali Therapeutics, Lowers Price Target to $28
Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
Decoding 7 Analyst Evaluations For Alkermes
Raymond James Reinstates Market Perform on Denali Therapeutics
Denali Therapeutics Analyst Ratings
Raymond James Reinstates Outperform on Immunovant, Announces $36 Price Target
Immunovant Analyst Ratings
Crinetics Pharmaceuticals Prices $500M Equity at $50 per Share
12 Health Care Stocks Moving In Monday's After-Market Session
Catalyst Watch: Tesla's Robotaxi Reveal, AI Events for Nvidia, AMD, and HP Enterprise
Capricor Stock Rallies 20% on DMD Data Presentation Update